Apraclonidina [Inn-Spanish] en es it fr

Apraclonidina [Inn-Spanish] Brand names, Apraclonidina [Inn-Spanish] Analogs

Apraclonidina [Inn-Spanish] Brand Names Mixture

  • No information avaliable

Apraclonidina [Inn-Spanish] Chemical_Formula

C9H10Cl2N4

Apraclonidina [Inn-Spanish] RX_link

http://www.rxlist.com/cgi/generic2/apraclonidine.htm

Apraclonidina [Inn-Spanish] fda sheet

Apraclonidina_[Inn-Spanish] FDA

Apraclonidina [Inn-Spanish] msds (material safety sheet)

Apraclonidina_[Inn-Spanish] MSDS

Apraclonidina [Inn-Spanish] Synthesis Reference

No information avaliable

Apraclonidina [Inn-Spanish] Molecular Weight

245.108 g/mol

Apraclonidina [Inn-Spanish] Melting Point

No information avaliable

Apraclonidina [Inn-Spanish] H2O Solubility

No information avaliable

Apraclonidina [Inn-Spanish] State

Solid

Apraclonidina [Inn-Spanish] LogP

1.53

Apraclonidina [Inn-Spanish] Dosage Forms

Liquid

Apraclonidina [Inn-Spanish] Indication

For short-term adjunctive therapy in patients on maximally tolerated medical therapy who require additional Intra Ocular Pressure (IOP) reduction.

Apraclonidina [Inn-Spanish] Pharmacology

Apraclonidine significantly lowers intraocular pressure with minimal effects on cardiovascular and pulmonary parameters. It lowers intraocular pressure by reducing aqueous humor production and increasing uveoscleral outflow.

Apraclonidina [Inn-Spanish] Absorption

No information avaliable

Apraclonidina [Inn-Spanish] side effects and Toxicity

No information avaliable

Apraclonidina [Inn-Spanish] Patient Information

No information avaliable

Apraclonidina [Inn-Spanish] Organisms Affected

Humans and other mammals